Evaxion A (EVAX) Gross Profit Margin starting from the fourth quarter 2025 to fourth quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Evaxion A  (NASDAQ: EVAX)


Evaxion A's Gross Profit Margin by quarter

Trends, Rankings, Statistics



EVAX Gross Profit Margin (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Revenue Change 125.12 %
Seq. Revenue Change -
Revenue In Millions $7.53
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 785
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2025 Gross Profit Margin



Observing fourth quarter 2025 results within Biotechnology & Pharmaceuticals industry 38 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
EVAX's Gross Profit Margin fourth quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 178
Overall # 785

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Dec 31 2025)  




Other Gross Profit Margin Profitability Ratios
EVAX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
EVAX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for EVAX's Competitors
Gross Profit Margin Profit Margin for Evaxion A's Suppliers
Gross Profit Margin Profit Margin for EVAX's Customers

You may also want to know
EVAX's Annual Growth Rates EVAX's Profitability Ratios EVAX's Asset Turnover Ratio EVAX's Dividend Growth
EVAX's Roe EVAX's Valuation Ratios EVAX's Financial Strength Ratios EVAX's Gross Profit Growth
EVAX's Roa EVAX's Inventory Turnover Ratio EVAX's Growth Rates EVAX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2025, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2025 MRQ Gross ProfitDec 31 2025 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.